<DOC>
	<DOCNO>NCT00822081</DOCNO>
	<brief_summary>This study compare efficacy tolerability/comfort brimonidine/timolol dorzolamide/timolol patient open-angle glaucoma ocular hypertension . In investigator mask randomization process , subject allocate recieve either brimonidine/timolol dorzolamide/timolol fixed-combination monotherapy adjuctive prostoglandin analogue period 12 week . After screen , patient return baseline , Month 1 , Month 3 ophthalmic evaluation .</brief_summary>
	<brief_title>Comparison Fixed Combinations Brimonidine/Timolol Dorzolamide/Timolol Subjects With Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Male female 18 yr . Female subject childbearing potential must negative pregnancy test provide contraception . Subjects must confirm diagnosis primary openangle glaucoma ocular hypertension eye . Subjects insufficiently responsive IOP reduce monotherapy use either study medication deem appropriate . Subjects able complete questionnaire provide informed consent . Female subject pregnant , plan become pregnant study period , breast feeding practice reliable method birth control . Subjects wherein study drug containdicated . Subjects introcular surgery 6 month ( 3 month laser ) . Subjects know side effects/ allergy sensitivity component study treatment . Subjects uncontrolled systemic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>